Twist Bioscience Corp. (TWST)
153.90
-5.88
(-3.68%)
USD |
NASDAQ |
Oct 12, 10:17
Twist Bioscience Free Cash Flow (Quarterly) : -8.648M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.648M |
| March 31, 2026 | -25.55M |
| December 31, 2025 | -34.79M |
| September 30, 2025 | -24.24M |
| June 30, 2025 | -10.56M |
| March 31, 2025 | -17.13M |
| December 31, 2024 | -23.70M |
| September 30, 2024 | -17.32M |
| June 30, 2024 | -7.343M |
| March 31, 2024 | -20.03M |
| December 31, 2023 | -24.48M |
| September 30, 2023 | -23.10M |
| June 30, 2023 | -27.92M |
| March 31, 2023 | -53.34M |
| December 31, 2022 | -65.89M |
| September 30, 2022 | -17.73M |
| June 30, 2022 | -74.77M |
| March 31, 2022 | -74.31M |
| Date | Value |
|---|---|
| December 31, 2021 | -59.44M |
| September 30, 2021 | -42.89M |
| June 30, 2021 | -34.90M |
| March 31, 2021 | -32.95M |
| December 31, 2020 | -28.56M |
| September 30, 2020 | -27.43M |
| June 30, 2020 | -26.32M |
| March 31, 2020 | -61.41M |
| December 31, 2019 | -36.97M |
| September 30, 2019 | -27.25M |
| June 30, 2019 | -27.25M |
| March 31, 2019 | -24.58M |
| December 31, 2018 | -23.61M |
| September 30, 2018 | -17.74M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -14.80M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -84.92M |
| Beam Therapeutics, Inc. | -68.51M |
| Prime Medicine, Inc. | -41.09M |
| Absci Corp. | -27.56M |
| 10X Genomics, Inc. | 15.39M |